Introducing a high-purity dual peptide formulation featuring 2.5mg of Cagrilintide and 2.5mg of Semaglutide. This synergistic blend is designed for advanced research focused on appetite regulation, metabolic studies, and peptide-based therapies. With exceptional stability and precision, this combination provides a versatile tool for scientific investigation into the combined mechanisms of GLP-1 receptor agonism and amylin analog activity.

Product Details:

• Name: Cagrilintide/Semaglutide 2.5mg/2.5mg

• Catalogue Number: CGS25

• Chemical Formula:

  • Cagrilintide: C176H275N47O53

  • Semaglutide: C187H291N45O59

• Molecular Weight:

  • Cagrilintide: ~3900 g/mol

  • Semaglutide: ~4113.6 g/mol

• Purity Level: ≥99%

• Physical Form: Lyophilized Powder

Applications and Research Potential:
This peptide blend is under investigation for its potential to impact weight regulation, glycaemic control, and energy balance. Semaglutide, a GLP-1 receptor agonist, is widely studied for its insulinotropic and appetite-suppressing effects. Cagrilintide, an amylin analogue, complements these effects by enhancing satiety signaling and slowing gastric emptying. Combined, researchers can explore their additive or synergistic roles in weight management and metabolic disorder models. For in-depth data, reference the National Centre for Biotechnology Information (NCBI).

Handling and Storage Instructions:
Supplied as a lyophilized powder to ensure long-term stability and ease of handling in research settings. For optimal reconstitution and storage practices, refer to the detailed guidelines provided on our website. Additional safety and handling recommendations are aligned with Health and Safety Executive (HSE) protocols.

Production and Quality Control:
Our Cagrilintide/Semaglutide blend is synthesized using cutting-edge peptide synthesis techniques and undergoes rigorous quality control testing to verify purity, identity, and consistency. Each batch is produced to meet stringent research-grade specifications. For more on our manufacturing standards, consult the British Pharmacopoeia (BP).

Regulatory and Safety Notes:
This product is strictly intended for laboratory research and is not approved for human or veterinary use. All handling should be performed by trained professionals in accordance with applicable safety and regulatory guidelines. Refer to the Medicines and Healthcare Products Regulatory Agency (MHRA) for more information.

Why Choose Kensington Labs?
Kensington Labs is dedicated to supporting scientific discovery through the provision of premium-quality research peptides. Our dual-action Cagrilintide/Semaglutide formulation enables researchers to pursue cutting-edge studies into metabolic health, obesity, and appetite regulation. Trust Kensington Labs for dependable, high-purity peptides that elevate your research.

Don’t forget your BACTERIOSTATIC WATER for mixing